Читать книгу Recent Advances in Dialysis Therapy in Japan - Группа авторов - Страница 30

1Nauta ST, van Domburg RT, Nuis RJ, Akkerhuis M, Deckers JW: Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era. Kidney Int 2016;90:878–887.

2Hanafusa N, Nakai S, Iseki K, Tsubakihara Y: Japanese Society for Dialysis Therapy Renal Data Registry – a window through which we can view the details of Japanese dialysis population. Kidney Int Suppl 2015;5:15–22.

3Saran R, Li Y, Robinson B, Abbott KC, et al: United States Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2016;67(suppl 1):Svii, S1–S305.

4Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Yamazaki S, Imai R, Okino K, Iwamoto N, Takahashi H, et al: Sympathetic overactivity and sudden cardiac death among hemodialysis patients with left ventricular hypertrophy. Int J Cardiol 2010;142:80–86.

5Nishimura M, Tsukamoto K, Tamaki N, Kikuchi K, Iwamoto N, Ono T: Risk stratification for cardiac death in hemodialysis patients without obstructive coronary artery disease. Kidney Int 2011;79:363–371.

6Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Yamazaki S, Imai R, Okino K, Takahashi H, Ono T: Myocardial fatty acid imaging identifies a group of hemodialysis patients at high risk for cardiac death after coronary revascularization. Kidney Int 2008;74:513–520.

7Jadoul M, Thumma J, Fuller DS, Tentori F, Li Y, Morgenstern H, Mendelssohn D, Tomo T, Ethier J, Port F, et al: Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol 2012;7:765–774.

8Moroi M, Tamaki N, Nishimura M, Haze K, Nishimura T, Kusano E, Akiba T, Sugimoto T, Hase H, Hara K, et al: Association between abnormal myocardial fatty acid metabolism and cardiac-derived death among patients undergoing hemodialysis: results from a cohort study in Japan. Am J Kidney Dis 2013;61:466–475.

9Tanaka Y, Hayashi T, Iwasaki M, Kubo S, Asakawa T, Matsukane A, Takahashi Y, Niikura H, Hirahata K, Imamura Y, Hase H: Coronary artery disease screening and prognosis in incident dialysis patients. Renal Replacement Ther 2016;2:22.

10Ramesh S, Zalucky A, Hemmelgarn BR, Roberts DJ, Ahmed SB, Wilton SB, Jun M: Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis. BMC Nephrol 2016;17:78.

11Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A: Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 1998;97:1514–1521.

12Herzog CA, Strief JW, Collins AJ, Gilbertson DT: Cause-specific mortality of dialysis patients after coronary revascularization: why don’t dialysis patients have better survival after coronary intervention? Nephrol Dial Transplant 2008;23:2629–2633.

13Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, Marre S, Cassottana P, Luca S, Vettoretti S, et al: Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension. Clin J Am Soc Nephrol 2016;11:271–279.

14Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE: Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension 2010;56:210–216.

15Hase H, Tsunoda T, Tanaka Y, Takahashi Y, Imamura Y, Ishikawa H, Inishi Y, Joki N: Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom. Kidney Int 2006;70:1142–1148.

16Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996;49:1379–1385.

17Wong MC, Kalman JM, Pedagogos E, Toussaint N, Vohra JK, Sparks PB, Sanders P, Kistler PM, Halloran K, Lee G, et al: Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease. J Am Coll Cardiol 2015;65:1263–1265.

18Silva RT, Martinelli Filho M, Peixoto Gde L, Lima JJ, Siqueira SF, Costa R, Gowdak LH, Paula FJ, Kalil Filho R, Ramires JA: Predictors of arrhythmic events detected by implantable loop recorders in renal transplant candidates. Arq Bras Cardiol 2015;105:493–502.

19Wang IK, Lin KH, Lin SY, Lin CL, Chang CT, Yen TH, Sung FC: Permanent cardiac pacing in patients with end-stage renal disease undergoing dialysis. Nephrol Dial Transplant 2016;31:2115–2122.

20Fotheringham J, Fogarty DG, El Nahas M, Campbell MJ, Farrington K: The mortality and hospitalization rates associated with the long interdialytic gap in thrice-weekly hemodialysis patients. Kidney Int 2015;88:569–575.

21Bleyer AJ, Russell GB, Satko SG: Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999;55:1553–1559.

22Foley RN, Gilbertson DT, Murray T, Collins AJ: Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 2011;365:1099–1107.

23Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G: Characteristics of sudden death in hemodialysis patients. Kidney Int 2006;69:2268–2273.

24Davis TR, Young BA, Eisenberg MS, Rea TD, Copass MK, Cobb LA: Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers. Kidney Int 2008;73:933–939.

25Roden DM: Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013–1022.

26Nie Y, Zou J, Liang Y, Shen B, Liu Z, Cao X, Chen X, Ding X: Electrocardiographic abnormalities and QTc interval in patients undergoing hemodialysis. PLoS One 2016;11:e0155445.

27Niemeijer MN, van den Berg ME, Eijgelsheim M, Rijnbeek PR, Stricker BH: Pharmacogenetics of drug-induced QT interval prolongation: an update. Drug Saf 2015;38:855–867.

28Genovesi S, Dossi C, Vigano MR, Galbiati E, Prolo F, Stella A, Stramba-Badiale M: Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace 2008;10:771–777.

29Pun PH, Horton JR, Middleton JP: Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol 2013;8:797–803.

30Di Iorio B, Torraca S, Piscopo C, Sirico ML, Di Micco L, Pota A, Tartaglia D, Berardino L, Morrone LF, Russo D: Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects. J Nephrol 2012;25:653–660.

31Schwartz HD, McConville BC, Christopherson EF: Serum ionized calcium by specific ion electrode. Clin Chim Acta 1971;31:97–107.

32Iwasaki M, Joki N, Tanaka Y, Hayashi T, Kubo S, Asakawa T, Matsukane A, Takahashi Y, Hirahata K, Imamura Y, et al: Declining prevalence of coronary artery disease in incident dialysis patients over the past two decades. J Atheroscler Thromb 2014;21:593–604.

33Slatopolsky E, Weerts C, Lopez-Hilker S, Norwood K, Zink M, Windus D, Delmez J: Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 1986;315:157–161.

Assoc. Prof. Nobuhiko Joki, MD, PhD

Division of Nephrology, Toho University Ohashi Medical Center

2-17-6 Ohashi, Meguro-Ku

Tokyo 153-8515 (Japan)

E-Mail jokinobuhiko@gmail.com